Millennium Management
CRBP icon

Millennium Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Millennium Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$413K – 6026
2024
Q3 		$413K Buy
+20,000
New +$1.02M ﹤0.01% 4977

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management's CRBP Position: Q1 2026 in Review

Millennium Management increased its Corbus Pharmaceuticals (CRBP) stake by 191% in Q1 2026, buying an estimated $596K and bringing the position to 107,800 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4385.

Millennium Management first reported a position in CRBP in Q3 2015 and has held it in 30 quarters since. The position peaked at $12.7M in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Millennium Management held 107,800 shares of Corbus Pharmaceuticals worth $1.01M as of Q1 2026.
  • Millennium Management bought 70,735 Corbus Pharmaceuticals shares in Q1 2026, an estimated $596K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4385 holding.
  • Millennium Management first reported a position in Corbus Pharmaceuticals in Q3 2015 and has held it in 30 quarters since.
  • Millennium Management's Corbus Pharmaceuticals position peaked at $12.7M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.